tiprankstipranks
Trending News
More News >
Shanghai Henlius Biotech, Inc. Class H (HK:2696)
:2696
Hong Kong Market

Shanghai Henlius Biotech, Inc. Class H (2696) Revenue

Compare
1 Followers

Shanghai Henlius Biotech, Inc. Class H Revenue

Shanghai Henlius Biotech, Inc. Class H had a revenue of 1.49B in the quarter ending Dec 31, 2024, with 0.00%. This bring the company's revenue in the last twelve months to 5.72B, Decreased 0.39%. In the fiscal year ending Dec 31, 2024, Shanghai Henlius Biotech, Inc. Class H had annual revenue of 5.72B with 6.11% growth.
Revenue (ttm)
5.72B
Revenue Growth
4.23%
P/S Ratio
4.97
Revenue/Employee
HK$1,628,577
Employees
3,515
Market Cap
HK$28.42B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
5.72B329.54M+6.11%
Dec 31, 2023
5.39B2.18B+67.82%
Dec 31, 2022
3.21B1.53B+91.07%
Dec 31, 2021
1.68B1.09B+186.34%
Dec 31, 2020
587.59M496.66M+546.20%
Dec 31, 2019
90.93M83.51M+1,125.29%
Dec 31, 2018
7.42M-26.49M-78.12%
Dec 31, 2017
33.91M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis